Literature DB >> 13130510

Role for M5 muscarinic acetylcholine receptors in cocaine addiction.

Anders Fink-Jensen1, Irina Fedorova, Gitta Wörtwein, David P D Woldbye, Thøger Rasmussen, Morgane Thomsen, Tom G Bolwig, Karen M Knitowski, David L McKinzie, Masahisa Yamada, Jürgen Wess, Anthony Basile.   

Abstract

Muscarinic cholinergic receptors of the M5 subtype are expressed by dopamine-containing neurons of the ventral tegmentum. These M5 receptors modulate the activity of midbrain dopaminergic neurons, which play an important role in mediating reinforcing properties of abused psychostimulants like cocaine. The potential role of M5 receptors in the reinforcing effects of cocaine was investigated using M5 receptor-deficient mice in a model of acute cocaine self-administration. The M5-deficient mice self-administered cocaine at a significantly lower rate than wild-type controls. In the conditioned place preference procedure, a classic test for evaluating the rewarding properties of drugs, M5-deficient mice spent significantly less time in the cocaine-paired compartment than control mice. Moreover, the severity of the cocaine withdrawal syndrome (withdrawal-associated anxiety measured in the elevated plus-maze) was significantly attenuated in mice lacking the M5 receptor. These results demonstrate that M5 receptors play an important role in mediating both cocaine-associated reinforcement and withdrawal. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13130510     DOI: 10.1002/jnr.10728

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  48 in total

Review 1.  Functional M3 muscarinic acetylcholine receptors in mammalian hearts.

Authors:  Zhiguo Wang; Hong Shi; Huizhen Wang
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

Review 2.  Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.

Authors:  Carrie K Jones; Nellie Byun; Michael Bubser
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

3.  Behavioral effects of morphine and cocaine in M1 muscarinic acetylcholine receptor-deficient mice.

Authors:  Kelly A Carrigan; Linda A Dykstra
Journal:  Psychopharmacology (Berl)       Date:  2007-01-09       Impact factor: 4.530

4.  Muscarinic acetylcholine receptor subtype expression in avian vestibular hair cells, nerve terminals and ganglion cells.

Authors:  G Q Li; G A Kevetter; R B Leonard; D J Prusak; T G Wood; M J Correia
Journal:  Neuroscience       Date:  2007-03-27       Impact factor: 3.590

Review 5.  Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions.

Authors:  Kalynda K Gonzales; Yoland Smith
Journal:  Ann N Y Acad Sci       Date:  2015-04-15       Impact factor: 5.691

6.  A Simple Representation of Three-Dimensional Molecular Structure.

Authors:  Seth D Axen; Xi-Ping Huang; Elena L Cáceres; Leo Gendelev; Bryan L Roth; Michael J Keiser
Journal:  J Med Chem       Date:  2017-08-08       Impact factor: 7.446

7.  Effects of muscarinic receptor antagonists on cocaine discrimination in wild-type mice and in muscarinic receptor M1, M2, and M4 receptor knockout mice.

Authors:  Lauren Joseph; Morgane Thomsen
Journal:  Behav Brain Res       Date:  2017-04-22       Impact factor: 3.332

8.  DAKB-GPCRs: An Integrated Computational Platform for Drug Abuse Related GPCRs.

Authors:  Maozi Chen; Yankang Jing; Lirong Wang; Zhiwei Feng; Xiang-Qun Xie
Journal:  J Chem Inf Model       Date:  2019-03-14       Impact factor: 4.956

9.  Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5: effects of drug and environmental treatments.

Authors:  Kazuko Sakata; Abigail E Overacre
Journal:  J Neurochem       Date:  2017-08-16       Impact factor: 5.372

10.  Muscarinic acetylcholine receptor binding affinities of pethidine analogs.

Authors:  Na-Ra Lee; Xuan Zhang; Mahesh Darna; Linda P Dwoskin; Guangrong Zheng
Journal:  Bioorg Med Chem Lett       Date:  2015-10-19       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.